Literature DB >> 8088067

Variability of lipid phenotypes in hyperuricaemic-hyperlipidemic patients.

E Collantes1, F J Tinahones, A Cisnal, J Añon, P Sanchez-Guijo.   

Abstract

We studied changes in the hyperuricaemia-associated lipid phenotypes of primary hyperuricaemic-hyperlipidemic patients, none of whom was obese, hypertensive or an alcohol drinker. The patients were monitored for three months during which they were placed on a strict diet. The results obtained showed that phenotype IIB was most frequently associated with hyperuricaemia, followed by phenotypes IV and IIA. Lipid phenotypes were found to change in most patients during the study, even though most of them remained hyperuricaemic-hyperlipidemic. We also determined apoprotein B in each determination and found that over half the patients possessed increased levels of this apolipoprotein. The results confirm that hyperuricaemia is not associated to a unique lipid phenotype since the phenotype of a given patient may change with time, even in the absence of propitiating external factors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088067     DOI: 10.1007/bf02249020

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Combined hyperlipoproteinemia. Evidence for a new lipoprotein phenotype.

Authors:  H G Rose; P Kranz; M Weinstock; J Juliano; J I Haft
Journal:  Atherosclerosis       Date:  1974 Jul-Aug       Impact factor: 5.162

2.  Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout.

Authors:  H Mielants; E M Veys; A de Weerdt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

Review 3.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Identification of the causes of persistent hyperuricaemia.

Authors:  B T Emmerson
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

5.  Effect of purine restriction on serum and urine urate in normal subjects.

Authors:  W Stafford; B T Emmerson
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

Review 6.  Pathogenesis of hyperlipoproteinemia.

Authors:  S M Grundy
Journal:  J Lipid Res       Date:  1984-12-15       Impact factor: 5.922

7.  Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

Authors:  J L Goldstein; H G Schrott; W R Hazzard; E L Bierman; A G Motulsky
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

8.  Family study of lipid and purine levels in gout patients.

Authors:  L G Darlington; J Slack; J T Scott
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

9.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors: 
Journal:  Arch Intern Med       Date:  1988-01

10.  [Changes in uric acid and blood lipids in patients with asymptomatic hyperuricemia treated with diet therapy in a rehabilitation procedure].

Authors:  W Kullich; A Ulreich; G Klein
Journal:  Rehabilitation (Stuttg)       Date:  1989-08       Impact factor: 1.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.